Showing results (321-330 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|March 23, 2020
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trialGary Middleton, Kristian Brock, Joshua Savage, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
The Lancet. Respiratory Medicine|March 18, 2020
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling studyAmin Adibi, Don D Sin, Abdollah Safari, et al.
The Lancet. Respiratory Medicine|December 12, 2018
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J Rhodes, Ken Batai, Marta Bleda, et al.
The Lancet. Respiratory Medicine|December 12, 2018
Acute respiratory failure in immunocompromised adultsElie Azoulay, Djamel Mokart, Achille Kouatchet, et al.
The Lancet. Respiratory Medicine|November 1, 2019
Malignant pleural effusion management: keeping the flood gates shutSteven Walker, Rachel Mercer, Nick Maskell, et al.
The Lancet. Respiratory Medicine|February 12, 2020
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trialJesús Villar, Carlos Ferrando, Domingo Martínez, et al.
The Lancet. Respiratory Medicine|January 18, 2020
Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trialsPratik Sinha, Kevin L Delucchi, Daniel F McAuley, et al.
The Lancet. Respiratory Medicine|January 20, 2019
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trialsCharles S Haworth, Diana Bilton, James D Chalmers, et al.
The Lancet. Respiratory Medicine|November 29, 2018
Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013Minghuan Wang, Xiang Luo, Shabei Xu, et al.
Pageof 103